Zihai Li, MD, PhD
@zihai
Founding Director, Pelotonia Institute for Immuno-Oncology (@OhioStatePIIO) • Deputy Director of @OSUCCC_James for Translational Research • Views My Own
ID: 52736312
https://cancer.osu.edu/piio 01-07-2009 14:16:05
4,4K Tweet
2,2K Followers
739 Following
Ready for the big 2024 Pelotonia ride weekend! Pelotonia Institute for Immuno-Oncology! Blake R. Peterson sizemorelabs #OneGoal #CancerFreeWorld
Post-Pelotonia ride celebration with Glen Barber Lab at The Shoe featuring Manchester City vs Chelsea (4:2). Pelotonia Institute for Immuno-Oncology Ohio State
Happy retirement to the heart and soul of Pelotonia Institute for Immuno-Oncology - Ms. Tamra Brooks, my amazing EA who was involved in getting me here from day one and has helped us to make what #PIIO is today! We will miss you so dearly Tam!!
A complete team work. Thanks to National Cancer Institute and all of my trainees, as well as my amazing collaborators, here and outside of Pelotonia Institute for Immuno-Oncology!! The goal of this grant is to advance our anti-GARP Ab to the clinics.
We are excited to welcome the new Immunology and Immunotherapeutics PhD Graduate Program (I2GP) cohort to The Ohio State University Wexner Medical Center The Ohio State University College of Medicine! We look forward to seeing all of your future successes…O-H-I-O!! Pelotonia Institute for Immuno-Oncology #MII Proud
Honored by Carl June guiding our cell therapy program within Pelotonia Institute for Immuno-Oncology and Zihai Li, MD, PhD with Dr. Ashley Krull, Ph.D. and Dr Lynn O'Donnell
Members of the National Academies of Sciences, Engineering, and Medicine (National Academies) describe the process and rationale for the development of the 2024 definition of persistent Covid-19 symptoms (long Covid). Read the Sounding Board article: nej.md/3SvLlxw
The Pelotonia Institute for Immuno-Oncology Annual Report highlights new recruits, scientific accomplishments, education updates & more! Many thanks to our #PIIOcommunity for supporting our ambition of being a leader in driving #ImmunoOncology breakthroughs. go.osu.edu/piioannualrepo…
Amazing night talking about life and science with our speaker The Colonna Lab of the joint campus-wide #immunology seminar series, along with Eugene Oltz, Amer Lab and Prosper Boyaka!! Pelotonia Institute for Immuno-Oncology The Ohio State University Wexner Medical Center The Ohio State University College of Medicine
Congratulations to Dr. Haitao Wen & team on their new research published in eLife - the journal that reveals that O-GlcNAc transferase (OGT) promotes #tumor growth by repressing the cGAS-STING pathway, impacting #antitumor #immunity. Targeting OGT could enhance immune response in
Welcome on board, Alex Blair !! Excited to learn from and work with you to advance IO for #PDAC and other IO-unfriendly cancers. Gunderlab Thomas Mace, Ph.D. Susan Tsai, MD, MHS Timothy M. Pawlik Zobeida Cruz-Monserrate Ph.D. etc
Proud of you Yuzhou Chang ! Keep it up!!
In tumor-infiltrating NK cells, the HSF1 transcription factor binds to mediators of effector function, negatively regulating NK cytotoxicity Nature Cell Biology Nikos Kourtis Iannis Aifantis Kate Hockemeyer nature.org/articles/s4155… nature.com/articles/s4155…
Shall be an exciting seminar. I am always fascinated about the mechanisms of immune privilege of stem cells - normal or malignant. Yuxuan (Phoenix) Miao Pelotonia Institute for Immuno-Oncology
Congrats to Matthew D. Park, Ph.D. Miriam Merad, MD, PhD Lipschultz Precision Immunology Institute and all for such an insightful finding!